A Bristish army nurse who contracted the deadly virus while volunteering in Sierra Leone has been discharged from a London hospital. Her recovery credits an experimental drug, named MIL77, developed by Chinese scientists.
The first success of MIL 77, an experimental drug for treating Ebola patients. Anna Cross, now free of the virus and well, is the first patient in the world to have received the Chinese-made treatment.
"Thanks to the team here who are, I would say, the best in the world at treating this disease. An absolutely incredible bunch of clinicians. Incredibly skilled, incredibly intelligent and incredibly professional. And yeah, thanks to them I'm alive. So a huge thank you," she said.
Anna Cross contracted the deadly disease after going to Sierra Leone in February to help care for victims of the outbreak there. She was brought back to Britain and successfully treated at the Royal Free Hospital, Britain's main center for Ebola treatment. The military nurse now is looking forward to getting out of hospital and returning to normal life.
"I'm literally just going to go and eat food and watch TV and do normal things. Coz it's so exciting right now because I've been in a bubble for the last two weeks so I've not been able to do anything. So I think going out to a restaurant will be just the most exciting thing," said Anna.
The Chinese-made MIL 77 drug is a close relative of another experimental medicine ZMapp. Thought it remains only experimental, doctors at the London hospital are satisfied with its use.
"It's impossible to say on the basis of treating one patient whether this experimental treatment was beneficial or not. But what I can tell you is that the treatment went very well, it caused no side effects that we were able to elicit, and we were very happy with its use," said Michael Jacobs, Royal Free Hospital.
The deadly virus ebola has killed more than 10,000 people, out of 25,000 infected in west africa since the beginning of 2014.
While some treatments have been proved their effectiveness, no licensed vaccine against the virus is available yet.